WebJul 22, 2024 · Novartis AG Q2 2024 earnings call dated Jul. 21, 2024Corporate Participants: Samir Shah — Global Head of Investor Relations. Vasant Narasimhan — Chief Executive Officer. Marie-France Tschudin — President of Novartis Pharmaceuticals. Susanne Schaffert — President of Novartis Oncology. Harry Kirsch — Chief Financial Officer. John Tsai — … Web1 day ago · Q2 AT&T Earnings Conference Call. Details. Thursday, July 22, 2024 Supporting Materials. News Release Slide Presentation Transcript. Date. July 09, 2024. Title. 4.750% Perpetual Preferred Stock, Series C Dividend Record Date - $296.875 per preferred share, or $0.296875 per depositary share ... May 24, 2024 Supporting Materials. News Release ...
Cogeco Communications Inc., Cogeco Inc., Q2 2024 Earnings Call, …
WebAug 3, 2024 · • Second-quarter 2024 earnings per share (EPS) decreased to $1.53 on a reported basis and increased to $1.87 on a non-GAAP basis. • 2024 EPS guidance updated to be in the range of $6.73 to $6.93 on a reported basis and remains in the range of $7.80 to $8.00 on a non-GAAP basis. WebApr 13, 2024 · AstraZeneca PLC (AZN) CEO Pascal Soriot on Q4 2024 Results - Earning Call Transcript. SA Transcripts Thu, Feb. 10, 2024. great hiding spots in house
Quarterly Results Vertex Pharmaceuticals
WebApr 14, 2024 · Presentation Operator MessageOperator Good day, and welcome to Cogeco Inc. and Cogeco Communications Inc. Q2 2024 Earnings Conference Call. Today's … WebJul 21, 2024 · Novartis AG 2024 Q2 - Results - Earnings Call Presentation SA Transcripts Wed, Jul. 21, 2024. Novartis (NVS) Iptacopan (LNP023) Update - Slideshow SA … WebJul 21, 2024 · Novartis AG (NYSE:NYSE:NVS) Q2 2024 Earnings Conference Call July 21, 2024 8:00 AM ETCompany ParticipantsSamir Shah - Global Head, IRVas Narasimhan - CEOHarry Kirsch - CFOMarie-France... floating animation in css